Detalles de la búsqueda
1.
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
Circulation
; 147(13): 1026-1038, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802876
2.
Monitoring of Argatroban in Critically Ill Patients: A Prospective Study Comparing Activated Partial Thromboplastin Time, Point-of-Care Viscoelastic Testing with Ecarin Clotting Time and Diluted Thrombin Time to Mass Spectrometry.
Anesthesiology
; 140(2): 261-271, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37787760
3.
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.
Stroke
; 53(2): 532-543, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645283
4.
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
N Engl J Med
; 380(14): 1326-1335, 2019 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730782
5.
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.
Thromb J
; 20(1): 48, 2022 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038895
6.
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis.
Crit Care
; 26(1): 180, 2022 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35710578
7.
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS.
J Thromb Thrombolysis
; 53(4): 777-787, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762222
8.
Survival and quality of life after early discharge in low-risk pulmonary embolism.
Eur Respir J
; 57(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859673
9.
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
J Thromb Thrombolysis
; 51(2): 349-358, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588288
10.
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
Eur Heart J
; 41(4): 509-518, 2020 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120118
11.
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis.
Circulation
; 149(16): 1315-1318, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38620086
12.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
N Engl J Med
; 376(13): 1211-1222, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28316279
13.
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
N Engl J Med
; 375(12): 1131-41, 2016 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27573206
14.
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
Eur J Haematol
; 102(2): 143-149, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328143
15.
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
Diabetes Obes Metab
; 21(9): 2107-2114, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099460
16.
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill.
Thromb J
; 17: 6, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31011294
17.
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients.
Thromb J
; 17: 24, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31889915
18.
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER).
Thromb J
; 17: 7, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31169831
19.
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.
Oncologist
; 23(7): 822-839, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650686
20.
Checkpoint inhibitors and thrombosis: what's up?
Blood
; 137(12): 1569-1570, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33764429